A Mattsson

1.0k total citations
19 papers, 807 citations indexed

About

A Mattsson is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, A Mattsson has authored 19 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Cancer Research. Recurrent topics in A Mattsson's work include Breast Cancer Treatment Studies (8 papers), Radiation Dose and Imaging (6 papers) and Global Cancer Incidence and Screening (3 papers). A Mattsson is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Radiation Dose and Imaging (6 papers) and Global Cancer Incidence and Screening (3 papers). A Mattsson collaborates with scholars based in Sweden, Greece and Denmark. A Mattsson's co-authors include L. E. Rutqvist, S Rotstein, R. Arriagada, A. Kramar, Lars Erik Rutqvist, Ulla Glas, Nils Wilking, Tommy� Fornander, Lennart Blomqvist and John Carstensen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and JNCI Journal of the National Cancer Institute.

In The Last Decade

A Mattsson

19 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Mattsson Sweden 12 418 298 225 219 185 19 807
HelenJ. Stewart United Kingdom 9 334 0.8× 231 0.8× 323 1.4× 183 0.8× 106 0.6× 19 777
Valentina Elisabetta Bounous Italy 18 176 0.4× 278 0.9× 176 0.8× 156 0.7× 199 1.1× 43 858
Marit Holmqvist Sweden 15 293 0.7× 329 1.1× 277 1.2× 174 0.8× 133 0.7× 19 766
G G Ribeiro United Kingdom 17 320 0.8× 255 0.9× 309 1.4× 169 0.8× 42 0.2× 26 850
Elizabeth Charlotte Moser Portugal 15 145 0.3× 280 0.9× 103 0.5× 147 0.7× 93 0.5× 39 792
K.-D. Schulz Germany 15 111 0.3× 160 0.5× 170 0.8× 88 0.4× 137 0.7× 31 634
Ingelise Jensen Denmark 14 585 1.4× 200 0.7× 48 0.2× 195 0.9× 98 0.5× 22 904
Richard M. Brohet Netherlands 12 337 0.8× 369 1.2× 710 3.2× 136 0.6× 57 0.3× 16 1.1k
C.D.M. Griffith United Kingdom 16 512 1.2× 465 1.6× 255 1.1× 280 1.3× 24 0.1× 27 980
Marta D’Alonzo Italy 10 186 0.4× 150 0.5× 138 0.6× 133 0.6× 106 0.6× 25 545

Countries citing papers authored by A Mattsson

Since Specialization
Citations

This map shows the geographic impact of A Mattsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Mattsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Mattsson more than expected).

Fields of papers citing papers by A Mattsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Mattsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Mattsson. The network helps show where A Mattsson may publish in the future.

Co-authorship network of co-authors of A Mattsson

This figure shows the co-authorship network connecting the top 25 collaborators of A Mattsson. A scholar is included among the top collaborators of A Mattsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Mattsson. A Mattsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bernardo, Carina, Subhayan Chattopadhyay, Pontus Eriksson, et al.. (2025). Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases. Experimental Hematology and Oncology. 14(1). 91–91. 1 indexed citations
2.
Abouzayed, Ayman, A Mattsson, Vladimir Tolmachev, et al.. (2024). GRPR-Antagonists Carrying DOTAGA-Chelator via Positively Charged Linkers: Perspectives for Prostate Cancer Theranostics. Pharmaceutics. 16(4). 513–513. 5 indexed citations
3.
Mattsson, A, Ayman Abouzayed, Berthold A. Nock, et al.. (2024). Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncology. EJNMMI Radiopharmacy and Chemistry. 9(1). 3 indexed citations
4.
Burman, Pia, A Mattsson, Gudmundur Johannsson, et al.. (2013). Deaths Among Adult Patients With Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased Mortality. The Journal of Clinical Endocrinology & Metabolism. 98(4). 1466–1475. 147 indexed citations
5.
Monson, JP, Roger Abs, Ulla Feldt‐Rasmussen, et al.. (2001). SAFETY AND MORTALITY DURING GROWTH HORMONE (GH) REPLACEMENT THERAPY IN 4457 ADULT GH-DEFICIENT PATIENTS - A KIMS DATABASE ANALYSIS. 1 indexed citations
6.
Holmberg, Erik, Lars‐Erik Holm, Marie Lundell, et al.. (2001). Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy. British Journal of Cancer. 85(3). 362–366. 34 indexed citations
7.
Mattsson, A, W. Leitz, & Lars Erik Rutqvist. (2000). Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life. British Journal of Cancer. 82(1). 220–226. 24 indexed citations
8.
Mattsson, A, et al.. (1999). Mortality after Long-Term Exposure to Radioactive Thorotrast: A Forty-Year Follow-Up Survey in Sweden. Radiation Research. 151(3). 293–293. 14 indexed citations
9.
Lindholm, Johan, et al.. (1998). Stereological estimates of nuclear volume in thin malignant melanomas. Melanoma Research. 8(5). 398–402. 1 indexed citations
10.
Dalberg, Kristina, A Mattsson, Lars Erik Rutqvist, et al.. (1997). Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences. Breast Cancer Research and Treatment. 43(1). 73–86. 45 indexed citations
11.
Mattsson, A, et al.. (1997). Incidence of Primary Malignancies Other Than Breast Cancer among Women Treated with Radiation Therapy for Benign Breast Disease. Radiation Research. 148(2). 152–152. 21 indexed citations
12.
Hall, Per, Carl Johan Fürst, A Mattsson, et al.. (1996). Thyroid Nodularity after Diagnostic Administration of Iodine-131. Radiation Research. 146(6). 673–673. 9 indexed citations
13.
Mattsson, A, et al.. (1995). Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease. British Journal of Cancer. 72(4). 1054–1061. 31 indexed citations
14.
Arriagada, R., L. E. Rutqvist, A Mattsson, A. Kramar, & S Rotstein. (1995). Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.. Journal of Clinical Oncology. 13(12). 2869–2878. 162 indexed citations
15.
Wilking, Nils, et al.. (1992). Prognostic Significance of Axillary Nodal Status in Primary Breast Cancer in Relation to the Number of Resected Nodes. Acta Oncologica. 31(1). 29–35. 74 indexed citations
16.
Fornander, Tommy�, L. E. Rutqvist, Björn Cedermark, et al.. (1991). Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality.. Journal of Clinical Oncology. 9(10). 1740–1748. 32 indexed citations
17.
Rutqvist, L. E., Björn Cedermark, Ulla Glas, et al.. (1991). Contralateral Primary Tumors in Breast Cancer Patients in a Randomized Trial of Adjuvant Tamoxifen Therapy. JNCI Journal of the National Cancer Institute. 83(18). 1299–1306. 113 indexed citations
18.
Mattsson, A. (1990). The Improbable Association between the Herbicide 2,4-D and Polyneuropathy. 1 indexed citations
19.
Fornander, Tommy�, et al.. (1990). Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.. Journal of Clinical Oncology. 8(6). 1019–1024. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026